![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 30, 2020 12:44:56 AM
SK may have data by early next year if the Trial fills with patients from the current wave of COVID there, even if we are not stuck with the bills. They have not stopped the Trial in SK, AGN just isn't paying more into it. Dr Williams helped design the Trials. He / AGN should take some credit.
I want the Phase 2b/3 Ifenprodil COVID International Trial to have strong initial results in early December and even better 28 day complete data for the whole Trial Asap after that.
I would think a bunch of more good press for Ifenprodil would be good for AGN...JMHFO... . . . ...
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM